Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical Outcome

11 Aug 2023

Abstract excerpt

Cyclin dependent kinase inhibitor 2A (CDKN2A) is a well-known tumor suppressor gene as it functions as a cell cycle regulator. While several reports correlate the malfunction of CDKN2A with the initiation and progression of several types of human tumors, there is a lack of a comprehensive study that analyzes the potential effect of CDKN2A genetic alterations on the human immune components and the consequences of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37626750
DOI: 10.3390/biomedicines11082254

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cyclin Dependent Kinase Inhibitor 2A Genetic and Epigenetic Alterations Interfere with Several Immune Components and Predict Poor Clinical OutcomePMID 37626750Read ↗

A multidimensional Pan-cancer analysis of CDKN1A identifies CDKN1A as an Immunological and Prognostic BiomarkerSemantic proximity Read ↗

An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)Semantic proximity Read ↗

CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer TypesSemantic proximity Read ↗

Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple CancersSemantic proximity Read ↗

Cyclin B1: A potential prognostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

Comprehensive analyses of cuproptosis-related gene CDKN2A on prognosis and immunologic therapy in human tumorsSemantic proximity Read ↗

Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer AnalysisSemantic proximity Read ↗

CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular CarcinomaSemantic proximity Read ↗

Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinomaSemantic proximity Read ↗

Covid-19 And Cancer: Insights Into Their Association And Influence On Genetic And Epigenetic LandscapeSemantic proximity Read ↗

A review on the role of cyclin dependent kinases in cancersSemantic proximity Read ↗

CDCA8, a mitosis-related gene, as a prospective pan-cancer biomarker: implications for survival prognosis and oncogenic immunologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.